2010 Hemostasis Gordon Research Conference and/or Gordon Research Seminar

2010 止血戈登研究会议和/或戈登研究研讨会

• 批准号: 7911112
• 负责人: Nigel Mackman
• 金额: $ 1万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-04-01 至 2011-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7911112
• 关键词: Anticoagulants; Area; Biology; Blood Clot; Blood Platelets; Blood coagulation; Cause of Death; Coagulation Process; Consultations; Diagnosis; Disabled Persons; Discipline; Disease; Fibrin; Goals; Hemostatic function; Hour; Individual; International; Location; Maine; Minority Groups; New Hampshire; Participant; Pathway interactions; Postdoctoral Fellow; Research; Science; Senior Scientist; Thrombosis; Time; Underrepresented Minority; Woman; Writing; college; design; graduate student; improved; meetings; planetary Atmosphere; posters; programs; public health relevance; symposium

DESCRIPTION (provided by applicant): This application seeks partial support for the bi-annual Gordon Conference (GRC) on Hemostasis and/or its preceding Gordon Research Seminar (GRS). The broad and long term goal of the conference is to increase our understanding of the fundamental mechanisms that regulate formation of a platelet-fibrin clot. The last two highly successful Hemostasis GRCs were held at Colby College, Maine in 2006 and Waterville Valley, New Hampshire in 2008. The next conference will be held on July 25th - July 30th 2010 at Waterville Valley Conference Center, Waterville Valley, New Hampshire. The 2008 found this venue to be a comfortable and inviting location. Always oversubscribed, well-attended, and highly evaluated by its participants, the GRC on Hemostasis for 2010 will be comprised of nine 3 hour sessions that will be held in the allotted morning and evening time slots. Poster presentations will be held before dinner on four of the five days. These are always very well-attended, and provide a dedicated, informal forum for interaction between junior and more senior scientists in the field. A Hot Topics Session, quickly becoming a tradition at our GRC, is planned for Wednesday night. The specific aims of this meeting will be to convene 39 Speakers and Discussion Leaders that represent critical areas of hemostasis research with a total of approx. 150 participants for a five day conference in a relatively isolated setting. The Speakers and Discussion Leaders have been carefully chosen by the Chair and Vice-Chair after extensive, careful consideration and consultation with former Chairs of the 2004, 2006, and 2008 Hemostasis GRC. Of these, we already have written acceptances from all participants. We have also made a concerted effort to achieve appropriate representation of women, racial and ethnic minorities, persons with disabilities, and other individuals from groups that have traditionally been underrepresented in science as Speakers and Discussion Leaders. Our current list of invited speakers and discussion leaders already includes 8 women, and we expect to increase the representation of women among our speakers, as well as including underrepresented minorities, in the Hot Topics session. The program is designed to provide an invigorating meeting covering a range of timely disciplines in the fields of thrombosis and hemostasis. A two day Gordon Research Seminar will precede the meeting and will allow post-docs and graduate students to interact in a more relaxed atmosphere. The significance of this application is that the Hemostasis GRC is widely considered to be the premiere small meeting on the topics of blood coagulation, platelet biology, and anticoagulant pathways, enjoying both national and international reputation. First organized by hemostasis pioneers Earl W. Davie and Oscar Ratnoff in 1973. The healthy relatedness of this application is that thrombosis is the leading cause of death in the US and there is an urgent need for improving diagnosis and treatment of this devastating disease. PUBLIC HEALTH RELEVANCE: Thrombosis is the leading cause of death in the US and there is an urgent need for improving diagnosis and treatment of this devastating disease. The goal of the conference is to increase our understanding of the fundamental mechanisms that regulate formation of a blood clot. The Hemostasis GRC is widely considered to be the premiere small meeting, on the topics of blood coagulation, platelet biology, and anticoagulant pathways, enjoying both national and international reputation.

描述（由申请人提供）： 本申请寻求对两年一度的戈登止血会议 (GRC) 和/或其之前的戈登研究研讨会 (GRS) 的部分支持。会议的广泛和长期目标是增加我们对调节血小板纤维蛋白凝块形成的基本机制的理解。上两届非常成功的止血 GRC 分别于 2006 年在缅因州科尔比学院和 2008 年在新罕布什尔州沃特维尔谷举行。下一次会议将于 2010 年 7 月 25 日至 7 月 30 日在新罕布什尔州沃特维尔谷会议中心举行。 2008 年发现这个场地是一个舒适且吸引人的地方。 2010 年止血 GRC 始终获得超额认购、出席人数众多且受到参与者高度评价，将由九场各 3 小时的会议组成，这些会议将在指定的早间和晚间时段举行。五天中的四天将在晚饭前进行海报展示。这些会议总是有很多人参加，并为该领域的初级和高级科学家之间的互动提供了一个专门的非正式论坛。热点话题会议计划在周三晚上举行，这很快就成为我们 GRC 的一项传统。本次会议的具体目标是召集 39 名代表止血研究关键领域的发言人和讨论领袖，总计约 10 名代表。 150 名与会者在相对孤立的环境中召开了为期五天的会议。发言人和讨论负责人是由主席和副主席在与 2004 年、2006 年和 2008 年止血 GRC 前任主席进行广泛、仔细的考虑和协商后精心挑选的。其中，我们已经收到了所有参与者的书面接受。我们还做出了共同努力，以实现妇女、种族和族裔少数群体、残疾人以及传统上在科学领域代表性不足的其他群体中的个人作为演讲者和讨论领袖的适当代表性。我们目前受邀的演讲者和讨论领袖名单中已包括 8 名女性，我们希望在热门话题会议中增加演讲者中女性的代表性，并包括代表性不足的少数族裔。该计划旨在提供一次令人振奋的会议，涵盖血栓形成和止血领域的一系列及时学科。会议之前将举行为期两天的戈登研究研讨会，让博士后和研究生在更轻松的氛围中互动。该应用的意义在于，Hemostasis GRC 被广泛认为是关于血液凝固、血小板生物学和抗凝途径主题的首个小型会议，享有国内和国际声誉。由止血先驱厄尔·W·戴维 (Earl W. Davie) 和奥斯卡·拉特诺夫 (Oscar Ratnoff) 于 1973 年首次组织。该应用的健康相关性在于，血栓形成是美国的首要死因，迫切需要改进这种破坏性疾病的诊断和治疗。公共卫生相关性：血栓形成是美国的主要原因，迫切需要改善这种破坏性疾病的诊断和治疗。会议的目标是增进我们对调节血块形成的基本机制的理解。止血 GRC 被广泛认为是关于凝血、血小板生物学和抗凝途径主题的首屈一指的小型会议，享有国内和国际声誉。